Canagliflozin Mediates Effective Blockade of the mTORC1 HIF-1a Pathway, Inhibits Growth and Enhances Non-Small Cell Lung Cancer (NSCLC) Response to Radiotherapy (RT)-论文-万方医学网

Canagliflozin Mediates Effective Blockade of the mTORC1 HIF-1a Pathway, Inhibits Growth and Enhances Non-Small Cell Lung Cancer (NSCLC) Response to Radiotherapy (RT)

导出原文传递

翻译打印收藏纠错

作者： Biziotis, O. D. ^[1] ; Tsakiridis, E. E. ^[2] ; Mekhaeil, B. ^[3] ; Wu, J. ; Zacharidis, P. ; Broadfield, L. A. ; Menjolian, G. ; Farrell, T. ; Abdulkarim, B. S. ; Muti, P. ; Steinberg, G. R. ; Tsakiridis, T.

作者单位： McMaster Univ, Hamilton, ON, Canada ^[1] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada ^[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada ^[3]

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Canagliflozin Mediates Effective Blockade of the mTORC1 HIF-1a Pathway, Inhibits Growth and Enhances Non-Small Cell Lung Cancer (NSCLC) Response to Radiotherapy (RT)

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Canagliflozin Mediates Effective Blockade of the mTORC1 HIF-1a Pathway, Inhibits Growth and Enhances Non-Small Cell Lung Cancer (NSCLC) Response to Radiotherapy (RT)

相似文献

相关期刊

检索历史清除